Concepedia
Statistics
Publications
62
Citations
4.3K
H-Index
30
Active since
1987
Affiliations
Precision Research Institute(Current)
Profil Institute for Clinical Research
University of Michigan
Eli Lilly (United States)
University of California San Diego
Linda Morrow is an author at Precision Research Institute specializing in medicine, diabetes mellitus, and pharmacology.
Publications per year
1987–2025
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 915 citations
Medicine, Endocrinology, Pharmacology +12
Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
Ralph A. DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula et al. · Diabetes Care · 2013 · 288 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes
Alan C. Moses, Simon C. Young, Linda Morrow et al. · Diabetes · 1996 · 282 citations
Medicine, Biochemistry, Endocrinology +14
Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability
Paula A. Rochon, Jeffrey N. Katz, Linda Morrow et al. · Medical Care · 1996 · 271 citations
Medicine, Geriatric Medicine, Geriatric Assessment +16
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
Damayanthi Devineni, Linda Morrow, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2012 · 221 citations
Medicine, Pharmacokinetics, Pharmacology +17
1–5 of 62